Home > Publications database > Combined lifestyle factors on mortality and cardiovascular disease among cancer survivors: a systematic review and meta-analysis of cohort studies. > print |
001 | 294812 | ||
005 | 20241204182818.0 | ||
024 | 7 | _ | |a 10.1007/s00520-024-09049-2 |2 doi |
024 | 7 | _ | |a pmid:39623080 |2 pmid |
024 | 7 | _ | |a pmc:PMC11611996 |2 pmc |
024 | 7 | _ | |a 0941-4355 |2 ISSN |
024 | 7 | _ | |a 1433-7339 |2 ISSN |
037 | _ | _ | |a DKFZ-2024-02524 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Zhu, Chunsu |0 P:(DE-He78)368f3ed21e01008fd56a1c7d3670c994 |b 0 |e First author |u dkfz |
245 | _ | _ | |a Combined lifestyle factors on mortality and cardiovascular disease among cancer survivors: a systematic review and meta-analysis of cohort studies. |
260 | _ | _ | |a New York,NY |c 2024 |b Springer |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1733320108_20390 |2 PUB:(DE-HGF) |x Review Article |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a #EA:C071#LA:C071# |
520 | _ | _ | |a Lifestyle factors in cancer survivors are frequently studied individually even though they are often interconnected. This systematic review and meta-analysis investigated the association of combined lifestyle factors on health outcomes among cancer survivors.EMBASE, PubMed and Web of Science were searched up to March 2024. Cohort studies examining the associations of at least three combined lifestyle factors with mortality (all-cause/cancer-specific) and cardiovascular disease (CVD) among cancer survivors, were selected. Pooled hazard ratios (pHRs) and 95% confidence intervals (CIs) were estimated using random effects models. Tests for heterogeneity and publication bias were conducted.Twenty-two studies involving 209,659 survivors with an average follow-up duration ranging from 4.1 to 29.1 years were included. pHRs(95%CI) comparing cancer survivors with the healthiest lifestyles versus those with the least healthy lifestyles were 0.57 (0.51-0.65) for all-cause mortality, 0.70 (0.61-0.80) for cancer-specific mortality, and 0.53 (0.46-0.63) for CVD incidence. These associations were largely consistent across subgroup analyses. Colorectal cancer survivors with the healthiest lifestyle experienced 37% lower all-cause mortality and 25% lower cancer-specific mortality, while breast cancer survivors had a 45% reduction in all-cause mortality. Although studies were limited, significant associations for all-cause mortality were observed among lung, liver, nasopharyngeal, gastric, kidney, gynecologic cancer survivors. However, no significant relationship between healthy lifestyles and CVD-specific mortality was detected.Having an overall healthy lifestyle is associated with lower CVD incidence and better survival among cancer survivors. The long-term management of cancer survivors should consider encouragement for a modification of multiple lifestyles. |
536 | _ | _ | |a 313 - Krebsrisikofaktoren und Prävention (POF4-313) |0 G:(DE-HGF)POF4-313 |c POF4-313 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
650 | _ | 7 | |a Cancer survivor |2 Other |
650 | _ | 7 | |a Cardiovascular disease |2 Other |
650 | _ | 7 | |a Lifestyle |2 Other |
650 | _ | 7 | |a Meta-analysis |2 Other |
650 | _ | 7 | |a Mortality |2 Other |
650 | _ | 7 | |a Systematic review |2 Other |
650 | _ | 2 | |a Humans |2 MeSH |
650 | _ | 2 | |a Cancer Survivors: statistics & numerical data |2 MeSH |
650 | _ | 2 | |a Cardiovascular Diseases: mortality |2 MeSH |
650 | _ | 2 | |a Cardiovascular Diseases: etiology |2 MeSH |
650 | _ | 2 | |a Cardiovascular Diseases: epidemiology |2 MeSH |
650 | _ | 2 | |a Life Style |2 MeSH |
650 | _ | 2 | |a Neoplasms: mortality |2 MeSH |
650 | _ | 2 | |a Cohort Studies |2 MeSH |
650 | _ | 2 | |a Risk Factors |2 MeSH |
700 | 1 | _ | |a Lian, Zhiwei |0 P:(DE-He78)f303fd16782cb36dee5eeffb83d0efca |b 1 |u dkfz |
700 | 1 | _ | |a Arndt, Volker |0 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0 |b 2 |u dkfz |
700 | 1 | _ | |a Thong, Melissa |0 P:(DE-He78)24fe6057396bec79d2638615b12eb989 |b 3 |e Last author |u dkfz |
773 | _ | _ | |a 10.1007/s00520-024-09049-2 |g Vol. 32, no. 12, p. 846 |0 PERI:(DE-600)1463166-0 |n 12 |p 846 |t Supportive care in cancer |v 32 |y 2024 |x 0941-4355 |
909 | C | O | |o oai:inrepo02.dkfz.de:294812 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)368f3ed21e01008fd56a1c7d3670c994 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)f303fd16782cb36dee5eeffb83d0efca |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)24fe6057396bec79d2638615b12eb989 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-313 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Krebsrisikofaktoren und Prävention |x 0 |
914 | 1 | _ | |y 2024 |
915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2023-10-21 |w ger |
915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2023-10-21 |w ger |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-21 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-21 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-21 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-10-21 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-21 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-10-21 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2023-10-21 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b SUPPORT CARE CANCER : 2022 |d 2023-10-21 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-21 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-21 |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2023-10-21 |
920 | 2 | _ | |0 I:(DE-He78)C071-20160331 |k C071 |l C071 Cancer Survivorship |x 0 |
920 | 1 | _ | |0 I:(DE-He78)C071-20160331 |k C071 |l C071 Cancer Survivorship |x 0 |
920 | 0 | _ | |0 I:(DE-He78)C071-20160331 |k C071 |l C071 Cancer Survivorship |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)C071-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|